S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Yorkville America Debuts 2X Inverse ETF Targeting MANGOS Plus Index

Yorkville America Equities has launched the 2X Inverse MANGOS Plus Daily Target ETF (MNGB), a new fund providing investors with -200% daily exposure to the Yorkville America MANGOS Plus Index ETF (FRUT). The product is engineered for active traders seeking to hedge positions or capitalize on short-term bearish volatility.

Yorkville America Debuts 2X Inverse ETF Targeting MANGOS Plus Index
Photo: Bio & News

Effective September 21, 2026, the MNGB fund utilizes a mix of swap agreements, put options, and physical short sales to track its inverse objective. Because the fund resets its exposure daily, the firm warns that performance over periods longer than one trading session may diverge sharply from the stated -200% target, particularly during market swings. The fund is intended strictly for sophisticated investors who possess the capacity to monitor their holdings continuously.

"Discipline treats the downside case with the same rigor as the upside—never as an afterthought," said Steve Neamtz, CEO of Yorkville America. The fund carries an expense ratio of 0.90% and is listed on both NYSE Arca and NYSE Texas. Tidal Investments serves as the sub-adviser for the product, which joins the firm’s broader platform of rules-based investment strategies. Prospective investors are cautioned that the fund carries significant risks, including the potential loss of principal, and is not designed as a long-term holding.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!